Managing diabetes in the middle-aged patient when loss of glycemic control occurs.

Abstract

PURPOSE:

The purpose of this article is to review the treatment of a patient with type 2 diabetes who is commonly seen in practice-specifically, a middle-aged obese patient with micro- and macrovascular complications whose A1C rises after therapeutic intervention. Discussion of glucose management, as well as hypertension, dyslipidemia, and obesity comorbidities, is included.

CONCLUSION:

The key to successful treatment is individualization of targets and therapeutic choices. GLP-1 receptor agonists have been shown to be effective in the treatment of type 2 diabetes, including aiding with A1C reduction and weight loss. Using a combination of old and new treatments for the management of diabetes can help to improve outcomes.

• Authors: Anne Peters
• Journal: The Diabetes educator (Diabetes Educ) 2012 Jul-Aug Vol. 38 Issue 4 Suppl Pg. 13S-21S; quiz 22S ISSN: 1554-6063 [Electronic] United States
• PMID: 22713264 (Publication Type: Case Reports, Journal Article, Review)

Chemical References

• Blood Glucose
• Glycated Hemoglobin A
• Hypolipidemic Agents
• hemoglobin A1c protein, human

Topics

• Blood Glucose (metabolism)
• Diabetes Mellitus, Type 2 (blood, diet therapy, drug therapy)
• Diet
• Female
• Glycated Hemoglobin (metabolism)
• Humans
• Hypertension (blood, diet therapy, drug therapy)
• Hypolipidemic Agents (therapeutic use)
• Middle Aged
• Obesity (blood, diet therapy, drug therapy)
• Patient Education as Topic
• Precision Medicine
• Risk Reduction Behavior
• Weight Loss